While these results are in agreement with the widely documented iron deregulation in Parkinson's disease, they also indicate that iron deposition is not due to HO-1 activity which is low in Nrf2−/− mice or non-existent in HO-1−/− mice. The gene discussed is NFE2L2; the disease is Parkinson disease.